Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/31/2025

Patterns of Muscle Weakness

Proximal Symmetric Pattern

  • The American College of Rheumatology suggests that symmetric proximal weakness of upper and lower limbs with neck flexor weakness is characteristic of idiopathic inflammatory myopathies, including polymyositis and dermatomyositis 1.
  • The European League Against Rheumatism states that inflammatory myopathies present with objective symmetric proximal muscle weakness of upper limbs, lower limbs, and neck flexors 1.
  • The evaluation should immediately seek bulbar symptoms (dysphagia, dysarthria, dysphonia) or respiratory compromise (dyspnea), as these indicate severe disease requiring high-dose methylprednisolone urgently 2.
  • The involvement of respiratory and bulbar muscles represents a medical emergency that requires urgent intervention and potential ICU admission 1.

Ascending Pattern (Guillain-Barré)

  • The National Institute of Neurological Disorders and Stroke indicates that Guillain-Barré syndrome is characterized by rapidly progressive bilateral weakness that typically starts in the legs and ascends to the arms and cranial muscles, accompanied by decreased or absent reflexes 3.
  • Paresthesias or sensory loss that precede or accompany weakness are characteristic of Guillain-Barré 3.

Facial and Bulbar Pattern (Congenital Myopathies)

  • The American Academy of Neurology suggests that congenital myopathies are characterized by hypotonia and weakness, usually from birth, with a static or slowly progressive clinical course 4.
  • The presence of prominent facial weakness with or without ptosis, generalized hypotonic posture with hyporeflexia, poor muscle mass, proximal muscle weakness, and respiratory and bulbar muscle dysfunction is suggestive of congenital myopathy 4.

Distal Pattern with Myotonia (Myotonic Dystrophy)

  • The American Heart Association states that cardiac manifestations are present in approximately 80% of patients with myotonic dystrophy type 1, and the risk of developing cardiac disease is higher in younger patients (2-30 years) 5.

Critical Diagnostic Considerations

  • The initial evaluation should include creatine kinase levels, thyroid function tests (TSH, free T4), and inflammatory markers (ESR, CRP) if inflammatory myopathy is suspected 2.
  • Specific myositis antibody panels (anti-Jo-1, anti-SRP) and electromyography (EMG) are essential for detecting myotonic discharges even when clinical myotonia is absent 2.
  • Muscle magnetic resonance imaging identifies inflammation and guides the site of biopsy, and muscle biopsy is necessary to distinguish subtypes of idiopathic inflammatory myopathies and confirm the diagnosis 2.

Common Pitfalls to Avoid

  • The American College of Rheumatology recommends that distinguishing between true muscle weakness (loss of power resulting in reduced motor function) and generalized fatigue is crucial through careful functional tests of muscle strength 1.
  • In adult dermatomyositis, immediate comprehensive oncologic screening should be performed due to the substantial risk of malignancy, including age-appropriate screening, chest/abdomen/pelvis CT, and tumor markers as clinically indicated 1.
  • Statin-induced myopathy can produce two distinct patterns: statin-associated myopathy and immune-mediated necrotizing myopathy (IMNM), which requires aggressive immunosuppression with high-dose corticosteroids, IVIG, and methotrexate 2.